These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 12948930

  • 1. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream.
    Peris K, Micantonio T, Fargnoli MC.
    Eur J Dermatol; 2003; 13(4):413-4; author reply 415. PubMed ID: 12948930
    [No Abstract] [Full Text] [Related]

  • 2. Topical treatment with imiquimod may induce regression of facial keratoacanthoma.
    Dendorfer M, Oppel T, Wollenberg A, Prinz JC.
    Eur J Dermatol; 2003; 13(1):80-2. PubMed ID: 12609789
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
    Tanghetti E, Werschler P.
    J Drugs Dermatol; 2007 Feb; 6(2):144-7. PubMed ID: 17373172
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.
    Aroni K, Mastoraki A, Agrogiannis G, Ioannidis E, Patsouris E.
    Int J Dermatol; 2007 Dec; 46(12):1321-2. PubMed ID: 18173541
    [No Abstract] [Full Text] [Related]

  • 5. Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris.
    Tsikeloudi M, Lallas A, Sidiropoulos T, Chasioti V, Lefaki I, Apalla Z.
    Clin Exp Dermatol; 2014 Jan; 39(1):60-2. PubMed ID: 23773180
    [No Abstract] [Full Text] [Related]

  • 6. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.
    Jorizzo J, Dinehart S, Matheson R, Moore JK, Ling M, Fox TL, McRae S, Fielder S, Lee JH.
    J Am Acad Dermatol; 2007 Aug; 57(2):265-8. PubMed ID: 17512087
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck.
    Olsen EA, Abernethy ML, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, McCray M, Monroe AB, Tschen E, Wolf JE.
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):738-43. PubMed ID: 1869646
    [Abstract] [Full Text] [Related]

  • 8. Imiquimod cream in the treatment of actinic keratoses.
    Persaud A, Lebwohl M.
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
    Harrison LI, Skinner SL, Marbury TC, Owens ML, Kurup S, McKane S, Greene RJ.
    Arch Dermatol Res; 2004 Jun; 296(1):6-11. PubMed ID: 15083310
    [Abstract] [Full Text] [Related]

  • 10. Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study.
    Misiewicz J, Sendagorta E, Golebiowska A, Lorenc B, Czarnetzki BM, Jablonska S.
    J Am Acad Dermatol; 1991 Mar; 24(3):448-51. PubMed ID: 2061443
    [Abstract] [Full Text] [Related]

  • 11. Treating actinic keratoses with imiquimod.
    Dixon A.
    Aust Fam Physician; 2007 May; 36(5):341-2. PubMed ID: 17492069
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
    Stockfleth E, Meyer T, Benninghoff B, Christophers E.
    Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream.
    Di Lernia V, Ricci C, Albertini G.
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):626-9. PubMed ID: 15324413
    [Abstract] [Full Text] [Related]

  • 15. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
    Stockfleth E, Sterry W, Carey-Yard M, Bichel J.
    Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
    [Abstract] [Full Text] [Related]

  • 16. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses.
    D'Addario S, Carrington PR.
    Acta Derm Venereol; 2006 Dec; 86(4):366-7. PubMed ID: 16874431
    [No Abstract] [Full Text] [Related]

  • 17. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD, Saini R, Caglar S, Weinberg JM, Crespo J.
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [Abstract] [Full Text] [Related]

  • 18. Topical imiquimod in the treatment of large facial keratoacanthomas.
    Cecchi R, Bartoli L, Brunetti L, Pavesi M.
    G Ital Dermatol Venereol; 2012 Oct; 147(5):505-7. PubMed ID: 23007258
    [No Abstract] [Full Text] [Related]

  • 19. Imiquimod as a possible treatment for keratoacanthoma.
    Bhatia N.
    J Drugs Dermatol; 2004 Oct; 3(1):71-4. PubMed ID: 14964750
    [Abstract] [Full Text] [Related]

  • 20. Detection and treatment of preclinical actinic keratoses (PAK).
    Kopera D, Kerl H.
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):693-4. PubMed ID: 20561117
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.